Taxotere Benefits and Side Effects

Taxotere has many life-extending benefits and for some it has a very devastating side effect

Thursday, November 9, 2017 - Taxotere is the brand name for the chemotherapy agent Docetaxel, marketed by Sanofi-Aventis, and used by cancer physicians to treat breast cancer, non-small cell lung cancer, prostate cancer and cancers of the head and neck and gastric intestinal system. The anti-cancer chemotherapy drug was first granted marketing approval in 1995 to treat breast cancer in women. Currently, Taxotere is the world's most widely used chemotherapy drug treating approximately 75% of the world's 3 million people suffering from cancer. The 3 million people diagnosed worldwide with cancer each year make for a multi-billion dollar annual market for the drug.

On the official Sanofi website, Taxotere claims to provide a significant benefit for men suffering from prostate cancer and in clinical studies published in the New England Journal of Medicine, has been found to increase the number of cancer patients who survive at least two-years by 30%. Because of the toxicity of Taxotere, cancer patients suffering from abnormal liver function experience an increased risk of treatment-related mortality. Patients also report a feeling of drunkenness after treatments due to the drugs high alcohol content and patients should be warned not to drive for a period after receiving treatment. Taxotere is a highly-toxic, anti-cancer chemotherapy drug prescribed to patients when a doctor feels that the risks are outweighed by the life-extension benefits. Severe nausea and vomiting are the most well known adverse side effects of the drug followed by diarrhea, lethargy, weight loss from loss of appetite, and hair loss amongst many others. Anti-cancer chemotherapy such as Taxotere reduces the body's ability to fight infection, therefore, a patient should watch for sores or lesions that develop that do not heal normally.

Patients using Taxotere are taking issue with doctors that do not fully explain one, very serious side effect. Doctors advise that hair loss will only be temporary, however, in approximately 10-15% of patient, permanent, irreversible hair loss, called Alopecia results. Taxotere patients are suing Sanofi claiming that they were unaware that Taxotere can cause permanent hair loss and had they been forewarned would have sought a less toxic form of treatment. Permanent hair loss in women can be a psychologically traumatic experience that some never recover from. Women who unexpectedly develope Alopecia report severe, immobilizing depression, some not even being able to get out of bed in the morning, let alone get up and go to work. Taxotere Alopecia entails complete and total hair loss including not only the hair on one's head, but also eyelashes, eyebrows, and all body hair. Some doctors are unaware of the Alopecia side effect of Taxotere and others feel that hair loss, whether permanent or temporary is merely a vanity issue unworthy of serious consideration. This is not so for thousands of women who are taking Sanofi-Aventis to court. As of August 2017 over 1900 Taxotere hair loss lawsuits have been filed against the company by women who allege Sanofi-Aventis knew as early as 2005 that the drug could cause permanent hair loss but failed to warn them.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Taxotere Patients Denied Their Right To Make An Informed Decision | 4/24/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Taxotere's Psychological Side Effects | 3/13/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Taxotere's Ambiguous Hair Loss Warning | 2/5/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis | 12/22/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Warnings Now Include Permanent Hair Loss | 6/19/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017
• Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients | 6/5/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.